DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo


8.14 -0.11 (-1.27%)

REAL-TIME: Last trade at

Extended Hours: $8.14 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

PDLI $8.14 -1.27%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.23
Previous Close $8.25
Daily Range $8.01 - $8.23
52-Week Range $7.22 - $10.26
Market Cap $1.3B
P/E Ratio 4.19
Dividend (Yield) $0.60 (7.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,658,506
Average Daily Volume 2,898,296
Current FY EPS $0.00





PDL BioPharma (PDLI) Description

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Website:

News & Commentary

3 Companies That Could Slash Their Dividends

Which stocks are in danger of a dividend cut? Our analysts think these three are prime candidates.

This High-Yield Dividend Stock Screams Danger

This high-yield dividend stock may be paying out north of 7%, but its long-term outlook might have investors wisely running in the opposite direction.

US Stock Futures Mostly Flat Ahead Of Housing Data

PDL BioPharma Announces Successful Conclusion Of Debt Financing Agreement With Durata Therapeutics

Buy-Rated Dividend Stocks In The Top 3: RGP, PDLI, SUI

Health Care Sector Update for 11/14/2014: PDLI, CASI, SYN

Healthcare's Top Dividend Paying Stocks

Top dividend paying stocks aren't easy to come by in the healthcare sector. Let's have a look at the five high-yielding stocks in healthcare and see if they'd be a good fit for your portfolio over the long term.

Company News for November 12, 2014 - Corporate Summary

How 7% Yielding PDL BioPharma Is Reinventing Itself

PDL BioPharma's Q3 Earnings and Revenues Increase Y/Y - Analyst Blog

See More PDLI News...

PDLI's Top Competitors

PDLI $8.14 (-1.27%)
Current stock: PDLI
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB